Cocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025

Core Points - Cocrystal Pharma, Inc. will participate in a fireside chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025 [1] - The event will be hosted by Zacks Small Cap Research Senior Analyst David Bautz, PhD [1] Company Overview - Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel antiviral therapeutics targeting the replication of various viruses, including influenza, coronaviruses (such as SARS-CoV-2), noroviruses, and hepatitis C [4] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs [4]